MiR-18a was reported to play an oncogenic role in CRC via the downregulation of ataxia telangiectasia mutated (ATM); ATM was identified as a miR-18a target gene and a key player in repair of DNA double-stranded breaks. The gene discussed is ATM; the disease is colorectal carcinoma.